Operating model design and investor-readiness
An EIC (European Innovation Council) Ecosystem Member programme, structured to take you from startup to scale-up.
SORS Diagnostic
A structured assessment of your growth foundations across team & HR, customer management, product development, process scalability, technology and AI infrastructure, financial operations, and legal & compliance.
Outcome: A roadmap to successful corporate integration and partnership.
Business Planning
We co-design the organisational and process infrastructure you need to grow from validated innovation to market-ready execution, paired with an executive specialised in your area - including rare disease, orphan drugs, or biotech.
Outcome: Investor-ready operating roadmap.
Mentoring and Execution
Ongoing 1-on-1 mentoring with senior pharma executives. We embed alongside your team to build the credibility you'll need with corporate partners, investors, and regulators.
Outcome: Executable operating model, corporate partnership readiness, and a closed execution gap.
3-Step Readiness Pathway
A structured programme that takes you from diagnostic to execution.
SORS™ Diagnostic
Structured assessment across seven operating pillars. Identifies gaps in validation, governance, scalability and execution risk.
Operating Model Design
Co-designed scaling roadmap covering positioning, customer journey, KPIs and regulatory alignment.
Cohort Implementation
8-12 week structured programme with expert guidance, accountability frameworks and performance governance.
Operating model design and investor-readiness
An EIC (European Innovation Council) Ecosystem Member programme, structured to take you from startup to scale-up.
A structured assessment of your growth foundations across team & HR, customer management, product development, process scalability, technology and AI infrastructure, financial operations, and legal & compliance.Outcome: A roadmap to successful corporate integration and partnership.
We co-design the organisational and process infrastructure you need to grow from validated innovation to market-ready execution, paired with an executive specialised in your area - including rare disease, orphan drugs, or biotech.Outcome: Investor-ready operating roadmap.
Ongoing 1-on-1 mentoring with senior pharma executives. We embed alongside your team to build the credibility you'll need with corporate partners, investors, and regulators.Outcome: Executable operating model, corporate partnership readiness, and a closed execution gap.
Who This Is For
Growth-stage life sciences innovators who:
-
Have a validated product or technology
-
Are in market deployment stage
-
Want to grow locally and/or internationally
-
Value stronger investor credibility
Why us
Unlike traditional incubators or accelerators, we focus on operational readiness for growth. We bring:
​
-
Success cases designing operating models
-
Deep understanding of regulated environments
-
Human-centric scaling (customer + employee integration)
-
A structured diagnostic platform that quantifies readiness
-
Investor and corporate innovation closeness
-
We're an official member of the EIC (European Innovation Council) ecosystem - vetted to support scale-ups through investor and corporate-partnership readiness.
We help you scale without chaos.
